Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Trending With Impact: Are NOTCH1 Variants Prognostic in Breast Cancer?

Oncotarget

February 24, 2022
Researchers determined the prognostic ability of three NOTCH1 gene variants by incorporating them into two non-tumorigenic breast cell lines. continue reading »

Behind the Study: CrkL Required for Donor T Cell Migration

Oncotarget

February 21, 2022
Dr. Mobin Karimi from Upstate Medical University at Syracuse describes the research behind a 2020 paper he co-authored that was published by Oncotarget, entitled, “CrkL is required for donor T cell migration to GvHD target organs.” continue reading »

Trending With Impact: New Pre-Transplant AML Treatment Combinations

Oncotarget

February 17, 2022
Researchers aimed to improve acute myeloid leukemia (AML) patient outcomes after allo-HSCT with new pre-transplant treatment combinations. continue reading »

Iron Chelators in Cancer Treatment

Trending

February 9, 2022
In a review paper published in Oncotarget in 2021, researchers discuss the impact of iron chelation on cancer cell survival and the underlying mechanisms of action. continue reading »

Behind the Study: Oncogenic Transformation and Iron Chelation

Oncotarget

February 7, 2022
Drs. Stephany Veuger and Gina Abdelaal from Northumbria University describe their 2021 review paper published by Oncotarget, entitled, "Reversing oncogenic transformation with iron chelation." continue reading »